BRTX — Biorestorative Therapies Share News
0.000.00%
Last trade - 00:00- $2.24m
- -$1.35m
- $0.36m
BioRestorative Therapies' Q3 revenue drops, net loss widens
Brief: BioRestorative Awarded Notice of Allowance for Japanese Patent
BioRestorative Therapies Inc reports results for the quarter ended June 30 - Earnings Summary
BioRestorative Therapies Inc expected to post a loss of 38 cents a share - Earnings Preview
Brief: BioRestorative Reports Compelling Preliminary Data For FDA-Fast-Tracked BRTX-100
BioRestorative Therapies Inc reports results for the quarter ended March 31 - Earnings Summary
BioRestorative Therapies Inc expected to post a loss of 32 cents a share - Earnings Preview
BioRestorative Therapies Inc expected to post a loss of 32 cents a share - Earnings Preview
Brief: BioRestorative confirms no material impact from reciprocal tariffs
BioRestorative Therapies Inc expected to post a loss of 28 cents a share - Earnings Preview
Brief: Biorestorative Therapies Inc - Patent Protection Expected Until April 2040
U.S. STOCKS ON THE MOVE-Charter Communications, BioNTech, Big US banks
U.S. STOCKS ON THE MOVE-BankUnited, Natera, Adaptimmune
BioRestorative Therapies Inc reports results for the quarter ended September 30 - Earnings Summary
U.S. STOCKS ON THE MOVE-Rivian, Amgen, Cava
Brief: Biorestorative Therapies Reports Positive Preliminary Phase 2 BRTX-100 Clinical Data
BioRestorative rises on preliminary data for bone disease cell therapy
BioRestorative Therapies Inc expected to post a loss of 43 cents a share - Earnings Preview
BioRestorative Therapies Inc reports results for the quarter ended in June - Earnings Summary